Collectively, our results showed that lncRNA‐ZEB2‐AS1/PI3K/Akt/GSK3β/Zeb2 axis facilitates tumor progression and is a potential prevention target in breast cancer. This evidence concerns the gene ZEB2 and breast carcinoma.